Startseite › Steatose der Leber › Texas › Austin
Klinische Studien zu Steatose der Leber in Austin, TX
13 Studien zu Steatose der Leber suchen Teilnehmer an Standorten in und um Austin (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Teilnehmer gesuchtPhase 3
- GSK Investigational Site, Austin
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Teilnehmer gesuchtPhase 3
- GSK Investigational Site, Austin
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Teilnehmer gesuchtPhase 2
- American Research Corporation, Austin
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Teilnehmer gesuchtPhase 2
- American Research Corporation, Austin
- Pinnacle Clinical Research - Austin, Austin
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Teilnehmer gesuchtPhase 3
- IMA Clinical Research Austin, Austin
- American Research Corporation, Austin
- Pinnacle Clinical Research, Austin
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Teilnehmer gesuchtPhase 3
- Akero Clinical Study Site, Austin
- Akero Clinical Study Site, Austin
- Akero Clinical Study Site, Austin
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Teilnehmer gesuchtPhase 3
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Teilnehmer gesuchtPhase 2
- Pinnacle Clinical Research, Austin
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Teilnehmer gesuchtPhase 3
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Teilnehmer gesuchtPhase 3
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Teilnehmer gesuchtPhase 2
- GSK Investigational Site, Austin
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Teilnehmer gesuchtPhase 3
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Teilnehmer gesuchtPhase 2
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
Steatose der Leber-Studien in anderen Städten
- San Antonio, TX17 Studien
- New York City, NY16 Studien
- Miami, FL16 Studien
- San Diego, CA14 Studien
- Houston, TX13 Studien
- Richmond, VA12 Studien
- Chandler, AZ10 Studien
- Tucson, AZ10 Studien
- Orlando, FL9 Studien
- Hialeah, FL9 Studien
- St. Louis, MO9 Studien
- Dallas, TX9 Studien
Weitere Studien in Austin
- Nichtkleinzelliges Lungenkarzinom30 Studien
- Krebs (alle Arten)20 Studien
- Adipositas20 Studien
- Metastasierender Krebs19 Studien
- Kolorektales Karzinom19 Studien
- Herzinsuffizienz18 Studien
- Brustkrebs18 Studien
- Übergewicht18 Studien
- Eierstockkrebs17 Studien
- Endometriumkarzinom15 Studien
- Prostatakrebs15 Studien
- Depression14 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.